Overview
A Study to Investigate How Safe and Effective Solifenacin Solution is in Treating Children/Adolescents With Symptoms of Overactive Bladder (OAB) Who Completed Study 905-CL-076
Status:
Completed
Completed
Trial end date:
2014-10-08
2014-10-08
Target enrollment:
0
0
Participant gender:
All
All
Summary
This was a 40-week study to investigate how safe and effective solifenacin solution was in treating children or adolescents with symptoms of overactive bladder (OAB), who completed study 905-CL-076 (NCT01565707).Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Astellas Pharma Europe B.V.Treatments:
Solifenacin Succinate
Criteria
Inclusion Criteria:- Subject has met the inclusion criteria of study 905-CL-076 and completed study
905-CL-076
Exclusion Criteria:
- Subject has failed the exclusion criteria of study 905-CL-076